October 13, 2018

ENVB: Enveric Biosciences, Inc. Stock

by Wilton Risenhoover

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M)	2.97
Enterprise Value ($M)	-0.15
Book Value ($M)	3.95
Book Value / Share	0.44
Price / Book	0.75
NCAV ($M)	3.50
NCAV / Share	0.39
Price / NCAV	0.85

Profitability (mra)
Return on Invested Capital (ROIC)	-2.49
Return on Assets (ROA)	-1.49
Return on Equity (ROE)	-4.05

Liquidity (mrq)
Quick Ratio	5.17
Current Ratio	5.17

Balance Sheet (mrq) ($M)
Current Assets	4.34
Assets	4.79
Liabilities	0.84
Debt	n/a
Equity	n/a

Income Statement (mra) ($M)
Revenue	0.00
Operating Income	0.00
Net Income	0.00
Earnings Per Share Basic And Diluted	n/a
Earnings Per Share Diluted	n/a
Earnings Per Share Basic	n/a

Cash Flow Statement (mra) ($M)
Cash From Operations	0.00
Cash from Investing	0.00
Cash from Financing	0.00
(click for more detail)

File Date	Form	Activist 13D/G Investors	Ownership (%)	Change (%)
11-14	13G/A	Armistice Capital, Llc	0.00	-100.00
11-13	13G/A	Intracoastal Capital, Llc	3.10	100.00
11-12	13G/A	AdvisorShares Trust	4.11	215.62
02-05	13G/A	Hudson Bay Capital Management LP	4.54	0.00

Top 13F Investors	Shares (1000)	Change (%)	Value ($1000)	Change (%)
(click for more detail)

Date	Insider Trades	Code	Shares	Value
(click for more detail)

File Date	Form	SEC Filings
2024-11-14	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: September 30, 2024 ☐ Transition Report Pursuan
2024-08-12	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the annual period ended: December 31, 2023 ☐ Transition Report Pursuant to Se
(click for more detail)

Short Volume
Market Date	Short Volume	Total Volume	Short Volume Ratio
2024-11-22	11,140	97,746	11.40
2024-11-21	26,830	179,097	14.98
2024-11-20	9,101	50,714	17.95
2024-11-19	7,537	96,760	7.79
(click for more detail)

Similar Companies
ENSC – Ensysce Biosciences, Inc.	ENTO – Entero Therapeutics, Inc.
ENTX – Entera Bio Ltd.	EPIX – ESSA Pharma Inc.
EQ – Equillium, Inc.

Financial data and stock pages provided by
Fintel.io

Related